Ukraine's antimonopoly committee fines pharma for illegal price hikes
This article was originally published in Scrip
Ukraine's antimonopoly committee (AMKU) has conducted 259 inspections of pharmaceutical manufacturers, wholesalers and retailers and initiated 101 legal investigations of competition law violations by the industry and regional healthcare authorities.
You may also be interested in...
Poland's president, Bronislaw Komorowski, has signed a reimbursement bill into the law which will come into force on 1 January.
In the past two years, most multinational pharmaceutical companies announced plans to create production facilities in Russia. They had been ignoring such an opportunity for years, and there were reasons for that. They included risks to investments, administrative barriers, unclear regulations assuming various interpretations and corruption.
Russia's president Dmitriy Medvedev has requested that his government start talks with the US and the EU on the mutual recognition of clinical trial results (including paediatric trials) and prepare proposals for corresponding amendments of existing regulations.